Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Salvatore V. Colucci
Observed names:
S Colucci,
S. Colucci,
Salvatore Colucci,
Salvatore V Colucci
Institution:
PTC Therapeutics (United States)
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Pfizer (United States),
Purdue Pharma (United States),
PTC Therapeutics (United States),
The University of Texas Health Science Center at Houston
OpenAlex ID:
A5041837726
Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily
2006
·
Paul B. Watkins
, Neil Kaplowitz
, et al.
·
JAMA
·
633
Long-term Use of Controlled-release Oxycodone for Noncancer Pain: Results of a 3-year Registry Study
2007
·
Russell K. Portenoy
, John T. Farrar
, et al.
·
Clinical Journal of Pain
·
200
Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse‐deterrent controlled‐release tablets in recreational opioid users
2013
·
Stephen C. Harris
, Peter J. Perrino
, et al.
·
The Journal of Clinical Pharmacology
·
60
PDF
Once-Weekly Transdermal Buprenorphine Application Results in Sustained and Consistent Steady-State Plasma Levels
2012
·
Ram P. Kapil
, Alessandra Cipriano
, et al.
·
Journal of Pain and Symptom Management
·
40
PDF
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
1999
·
J M Russell
, E R Berndt
, et al.
·
PubMed
·
39
Attractiveness of reformulated OxyContin ® tablets: assessing comparative preferences and tampering potential
2013
·
Edward M Sellers
, Peter J Perrino
, et al.
·
Journal of Psychopharmacology
·
34
Effect of Ketoconazole on the Pharmacokinetic Profile of Buprenorphine following Administration of a Once-Weekly Buprenorphine Transdermal System
2012
·
Ram P. Kapil
, Alessandra Cipriano
, et al.
·
Clinical Drug Investigation
·
34
Pharmacokinetics, Tolerability, and Safety of Intranasal Administration of Reformulated OxyContin® Tablets Compared with Original OxyContin® Tablets in Healthy Adults
2013
·
Peter J. Perrino
, Salvatore V. Colucci
, et al.
·
Clinical Drug Investigation
·
33
PDF
Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials
2016
·
Stephen C. Harris
, Joel Morganroth
, et al.
·
Postgraduate Medicine
·
29
PDF
Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain
2018
·
Eric B. Laber
, Fan Wu
, et al.
·
Statistics in Medicine
·
25
PDF
Abuse Potential of Intravenous Oxycodone/Naloxone Solution in Nondependent Recreational Drug Users
2014
·
Salvatore V. Colucci
, Peter J. Perrino
, et al.
·
Clinical Drug Investigation
·
25
PDF
Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users
2015
·
Stephen C. Harris
, Alessandra Cipriano
, et al.
·
Pain Medicine
·
21
The Effect of Selective Serotonin Reuptake Inhibitor Treatment of Panic Disorder on Emergency Room and Laboratory Resource Utilization
2001
·
Peter P. Roy-Byrne
, Cathryn M. Clary
, et al.
·
The Journal of Clinical Psychiatry
·
19
Clinical evaluation of dentinal hypersensitivity: A comparison of methods
1986
·
Joseph A. Kanapka
, Salvatore V. Colucci
·
Dental Traumatology
·
17
Clinician Validation of Poison Control Center (PCC) Intentional Exposure Cases Involving Prescription Opioids
2006
·
Meredith Y. Smith
, Richard Dart
, et al.
·
The American Journal of Drug and Alcohol Abuse
·
16
Safety of buprenorphine transdermal system in the management of pain in older adults
2016
·
Joseph V. Pergolizzi
, Robert B. Raffa
, et al.
·
Postgraduate Medicine
·
15
PDF
Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users
2016
·
Stephen C. Harris
, Alessandra Cipriano
, et al.
·
Pain Medicine
·
14
PDF
Comparing SSRI Treatment Costs for Depression Using Retrospective Claims Data: The Role of Nonrandom Selection and Skewed Data
2000
·
Ernst R. Berndt
, James M. Russell
, et al.
·
Value in Health
·
13
Validity of Self-Reported Misuse of Prescription Opioid Analgesics
2010
·
Meredith Smith
, Andrew Rosenblum
, et al.
·
Substance Use & Misuse
·
11
Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent Properties
2015
·
Ram P. Kapil
, Alessandra Cipriano
, et al.
·
Clinical Therapeutics
·
4
(441) A single-center, randomized, double-blind crossover study to evaluate the abuse potential, pharmacokinetics, and safety of milled and intranasally administered extended-release hydrocodone (HYD) in recreational opioid users
2014
·
S. Harris
, S. Colucci
, et al.
·
Journal of Pain
·
4
PDF
(440) A single-center, randomized, double-blind, crossover study to evaluate the abuse potential, pharmacokinetics, and safety of oral milled and intact extended-release hydrocodone (HYD) tablets in recreational opioid users
2014
·
S. Harris
, S. Colucci
, et al.
·
Journal of Pain
·
3
PDF
Effect of Ataluren on Age at Loss of Ambulation in Nonsense Mutation Duchenne Muscular Dystrophy: Observational Data from the STRIDE Registry (P1.6-067)
2019
·
Abdallah Delage
, Filippo Bucella
, et al.
·
Neurology
·
1
Pharmacokinetic–pharmacodynamic analyses in the assessment of abuse-deterrent opioid formulations
2014
·
Megan Shram
, Salvatore Colucci
, et al.
·
Drug and Alcohol Dependence
·
1
Serum Transaminase Levels Should Be Measured Immediately Prior to Dosing in Early Phase I Clinical Trials
2010
·
David Groen
, Stephen Harris
, et al.
·
The Journal of Clinical Pharmacology
·
1
Show more works
View as search
Works count:
32
Citation count:
1,293
H-index:
15
I10-index:
19
Year
Topic
Type
